Commentary on NICE guidelines for alteplase for the treatment of acute ischaemic stroke

Heart

Volumn 93, Issue 12, 2007, Pages 1617-1618

  Lindley, R I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ACUTE HEART INFARCTION; ASSAULT; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY CARE UNIT; DRUG EFFICACY; ELECTROCARDIOGRAM; HEALTH CARE COST; HUMAN; MEDICAL DECISION MAKING; NOTE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRACTICE GUIDELINE; PRIORITY JOURNAL;

FIBRINOLYTIC AGENTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; STROKE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TISSUE PLASMINOGEN ACTIVATOR;

EID: 36749072124     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.128835     Document Type: Note

References (16)

1. NICE. Alteplase for the treatment of acute ischaemic stroke. NICE technology appraisal guidance 122. June 2007. Available at http://www.nice.org.uk/TA122 (accessed 18 September 2007).
2. Anonymous. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
3. Ingall TJ, O'Fallon WM, Asplund K, et al. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke 2004;35:2418-24.
4. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational stud. [see comment]. Lancet 2007;369:275-82.
5. Anonymous. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994;343:311-22.
6. Hand PJ, Wardlaw JM, Rowat AM, et al. Magnetic resonance brain imaging in patients with acute stroke: feasibility and patient related difficulties. J Neurol Neurosurg Psychiatry 2005;76:1525-7.
7. Matchar DB, Samsa GP, Knight T, et al. Thrombolytic Usage for acute ischemic stroke as reflected in medicare 2002 and 2004 claims files: rates and determinants of use. Stroke 2007;38:459.
8. Grotta JC, Burgin WS, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 2001;58:2009-13.
9. Ketley D, Woods KL. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet 1993;342:891-4.
10. Horowitz SH. Thrombolytic therapy in acute stroke: neurologists, Get off your hands! Arch Neurol 1998;55:155-7.
11. Audebert HJ, Kukla C, Clarmann von CS, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke 2005;36:287-91.
12. Hand PJ, Kwan J, Lindley RI, et al. Distinguishing between stroke and mimic at the bedside: the brain attack study [see comment]. Stroke 2006;37:769-75.
13. Wardlaw JM, Seymour J, Cairns J, et al. Immediate computed tomography scanning of acute stroke is cost-effective and improves quality of life. Stroke 2004;35:2477-83.
14. Wardlaw JM, Farrall AJ, Perry D, et al. Factors influencing the detection of early CT signs of cerebral ischemia: an internet-based, international multiobserver study. Stroke 2007;38:1250-6.
15. Morgenstern LB, Staub L, Chan W, et al. Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke 2002;33:160-6.
16. Harbison J, Hossain O, Jenkinson D, et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003;34:71-6.